272 related articles for article (PubMed ID: 32340551)
21. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML
Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944
[TBL] [Abstract][Full Text] [Related]
23. Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19.
Fu J; Wei C; He J; Zhang L; Zhou J; Balaji KS; Shen S; Peng J; Sharma A; Fu J
Int J Biol Sci; 2021; 17(3):897-910. PubMed ID: 33767597
[TBL] [Abstract][Full Text] [Related]
24. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
[TBL] [Abstract][Full Text] [Related]
25. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
Molecules; 2020 May; 25(11):. PubMed ID: 32485894
[TBL] [Abstract][Full Text] [Related]
26. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.
Basu A; Sarkar A; Maulik U
Sci Rep; 2020 Oct; 10(1):17699. PubMed ID: 33077836
[TBL] [Abstract][Full Text] [Related]
27. Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.
Baig MS; Alagumuthu M; Rajpoot S; Saqib U
Drugs R D; 2020 Sep; 20(3):161-169. PubMed ID: 32592145
[TBL] [Abstract][Full Text] [Related]
28.
Bhowmik A; Biswas S; Hajra S; Saha P
Heliyon; 2021 Jan; 7(1):e05923. PubMed ID: 33458435
[TBL] [Abstract][Full Text] [Related]
29. Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.
Martin WR; Cheng F
J Proteome Res; 2020 Nov; 19(11):4670-4677. PubMed ID: 32907334
[TBL] [Abstract][Full Text] [Related]
30. Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2.
Al-Khafaji K; Al-Duhaidahawi D; Taskin Tok T
J Biomol Struct Dyn; 2021 Jun; 39(9):3387-3395. PubMed ID: 32364041
[TBL] [Abstract][Full Text] [Related]
31. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.
Prasad K; Ahamad S; Kanipakam H; Gupta D; Kumar V
ACS Chem Neurosci; 2021 Mar; 12(5):930-944. PubMed ID: 33606519
[TBL] [Abstract][Full Text] [Related]
33. Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches.
Francés-Monerris A; Hognon C; Miclot T; García-Iriepa C; Iriepa I; Terenzi A; Grandemange S; Barone G; Marazzi M; Monari A
J Proteome Res; 2020 Nov; 19(11):4291-4315. PubMed ID: 33119313
[TBL] [Abstract][Full Text] [Related]
34. Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach.
Dhasmana A; Kashyap VK; Dhasmana S; Kotnala S; Haque S; Ashraf GM; Jaggi M; Yallapu MM; Chauhan SC
Curr Pharm Des; 2020; 26(41):5300-5309. PubMed ID: 32867645
[TBL] [Abstract][Full Text] [Related]
35. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach.
Enmozhi SK; Raja K; Sebastine I; Joseph J
J Biomol Struct Dyn; 2021 Jun; 39(9):3092-3098. PubMed ID: 32329419
[TBL] [Abstract][Full Text] [Related]
36. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.
Maurya VK; Kumar S; Prasad AK; Bhatt MLB; Saxena SK
Virusdisease; 2020 Jun; 31(2):179-193. PubMed ID: 32656311
[TBL] [Abstract][Full Text] [Related]
37.
de Oliveira DF
J Biomol Struct Dyn; 2023 Nov; ():1-19. PubMed ID: 37921757
[TBL] [Abstract][Full Text] [Related]
38. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection.
Palmeira A; Sousa E; Köseler A; Sabirli R; Gören T; Türkçüer İ; Kurt Ö; Pinto MM; Vasconcelos MH
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32630514
[TBL] [Abstract][Full Text] [Related]
39. Design of a potent anticancer lead inspired by natural products from traditional Indian medicine.
Arya H; Yadav CS; Lin SY; Syed SB; Charles MRC; Kannadasan S; Hsieh HP; Singh SS; Gajurel PR; Coumar MS
J Biomol Struct Dyn; 2020 Aug; 38(12):3563-3577. PubMed ID: 31526250
[TBL] [Abstract][Full Text] [Related]
40. Binding insight of clinically oriented drug famotidine with the identified potential target of SARS-CoV-2.
Sen Gupta PS; Biswal S; Singha D; Rana MK
J Biomol Struct Dyn; 2021 Sep; 39(14):5327-5333. PubMed ID: 32579065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
